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Surgery of T4 lung cancer tumors with vertebral involvement
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Background: Surgery is a radical treatment in lung cancer, and the 
only one that can change the natural evolution of this disease. In re-
sected patients, the main prognostic factor is the complete resection and 
the mediastinal nodes affectation (N2). Surgical treatment in advanced 
stages is not clearly deﬁned, but it is known that patients with locally 
advanced stages (T3-T4) that can be treated with complete surgical 
resection have better prognosis than those in which mediastinal dis-
semination of the disease exists.
Patients with direct vertebral invasion present a 2-year survival rate 
of 15%. Adjuvant chemotherapy (CT) and radiotherapy (RT) and 
advances in techniques for vertebral ﬁxation allow a complete resection 
with good long-term results. (The survival at two year is 55%)
We present a review of 4 lung cancer patients with vertebral invasion 
treated surgically by the Department of Thoracic Surgery and Trauma-
tology in our hospital.
Methods: Between 2000 and 2006, 4 male patients with an average 
age of 50 years (range: 43-55 years) underwent surgical treatment. In 
all the patients the tumor was located in the superior pulmonary lobes, 
affecting costal archs and vertebral bodies. In 2 of them the pathologi-
cal diagnostic was positive for adenocarcinoma, and the other two were 
positive for large cell carcinoma.
Results: All the patients were treated with postoperative CT and RT. 
Prone decubitus position was used in 3 of the cases during the surgical 
procedure. In one patient a complete exeresis of 2 vertebral bodies was 
performed. All the patients are alive, and one of them has been a 5-year 
disease- free survival.
Conclusions: Surgical treatment of lung cancer with vertebral involve-
ment is indicated in selected cases, in patients with a good general 
state, negative N2 and possibility of complete resection.
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Adrenalectomy for metastases from lung cancer
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Background: The surgery is the treatment of lung cancer. In cases of 
unique adrenal metastases, the surgical resection obtains better survival 
(of patients) than Chemotherapy treatment. The prevalence of adrenal 
metastases in resectable pulmonary tumors in different series varies 
between 1.6% and 3.5%. We made a retrospective study of 18 oper-
ated patients in Vall d’ Hebrón Hospital between October of 1996 and 
March of 2007. The objective was to select patient subgroups most 
likely to beneﬁt from adrenalectomy surgery like the multimodal treat-
ment.
Methods: 18 patients are included with an average age of 54.94 years.
Pathological diagnostic was positive for adenocarcinoma in 13 patients. 
All of them were negative N2. In one case the adrenal metastases were 
bilateral, contralateral in seven cases and in 10 of them they were 
ipsilateral to the pulmonary tumor. The adrenal glands were removed 
through a subcostal incision or by videolaparoscopy. As regards to 
postoperative complications, a case of pneumonia and paralytic ileus 
appeared.
Results: The patients with synchronous metastases have a median 
survival of 33 months. Patients with metacronic metastases have a 
median survival of 25,73 months and a median disease free survival of 
15 months.
In our serie the 5 year survival is 40%.
Conclusions: Surgical treatment of lung cancer patients and solitary 
adrenal metastasis improves survival of patients.
It is surgery that presents very few complications.
It is only indicated in selected cases in which metastatic disease does 
not exist in other locations.
